CBS - The 17th Left Main & Coronary Bifurcation Summit, CBS2025

左主干支架

Clinical Outcome After DK Crush Versus Culotte Stenting of Distal Left Main Bifurcation Lesions: The 3-Year Follow-Up Results of the DKCRUSH-III Study Second vs. First generation drug eluting stents in multiple vessel disease and left main stenosis: Two-year follow-up of the observational, prospective, controlled, and multicenter ERACI IV registry Long-term results after PCI of unprotected distal left main coronary artery stenosis: the Bifurcations Bad Krozingen (BBK)-Left Main Registry Ten-Year All-Cause Death According to Completeness of Revascularization in Patients With Three-Vessel Disease or Left Main Coronary Artery Disease: Insights From the SYNTAX Extended Survival Study Impact of Staging Percutaneous Coronary Intervention in Left Main Artery Disease: Insights From the EXCEL Trial Why NOBLE and EXCEL Are Consistent With Each Other and With Previous Trials Complex PCI procedures: challenges for the interventional cardiologist Comparison of Outcomes of Percutaneous Coronary Intervention on Native Coronary Arteries Versus on Saphenous Venous Aorta Coronary Conduits in Patients With Low Left Ventricular Ejection Fraction and Impella Device Implantation Achieved or Attempted (from the PROTECT II Randomized Trial and the cVAD Registry)

Sort by hits |<<... 3 4 5 6 7 8 9 ...>>|

Original ResearchVolume 72, Issue 18, October 2018

JOURNAL：JACC Article Link

Coronary CT Angiographic and Flow Reserve-Guided Management of Patients With Stable Ischemic Heart Disease

BL Nørgaard, CJ Terkelsen, ON Mathiassen et al. Keywords: computed tomography; angiography; coronary angiography; coronary artery disease; fractional flow reserve

ABSTRACT

BACKGROUND - Clinical outcomes following coronary computed tomography–derived fractional flow reserve (FFR_CT) testing in clinical practice are unknown.

OBJECTIVES - This study sought to assess real-world clinical outcomes following a diagnostic strategy including first-line coronary computed tomography angiography (CTA) with selective FFR_CTtesting.

METHODS - The study reviewed the results of 3,674 consecutive patients with stable chest pain evaluated with CTA and FFR_CT testing to guide downstream management in patients with intermediate stenosis (30% to 70%). The composite endpoint (all-cause death, myocardial infarction, hospitalization for unstable angina, and unplanned revascularization) was determined in 4 patient groups: 1) CTA stenosis <30%, optimal medical treatment (OMT), and no additional testing; 2) FFR_CT >0.80, OMT, no additional testing; 3) FFR_CT ≤0.80, OMT, no additional testing; and 4) FFR_CT ≤0.80, OMT, and referral to invasive coronary angiography. Patients were followed for a median of 24 (range 8 to 41) months.

RESULTS - FFR_CT was available in 677 patients, and the test result was negative (>0.80) in 410 (61%) patients. In 75% of the patients with FFR_CT >0.80, maximum coronary stenosis was ≥50%. The cumulative incidence proportion (95% confidence interval [CI]) of the composite endpoint at the end of follow-up was comparable in groups 1 (2.8%; 95% CI: 1.4% to 4.9%) and 2 (3.9%; 95% CI: 2.0% to 6.9%) (p = 0.58) but was higher (when compared with group 1) in groups 3 (9.4%; p = 0.04) and 4 (6.6%; p = 0.08). Risk of myocardial infarction was lower in group 4 (1.3%) than in group 3 (8%; p < 0.001).

CONCLUSIONS - In patients with intermediate-range coronary stenosis, FFR_CT is effective in differentiating patients who do not require further diagnostic testing or intervention (FFR_CT >0.80) from higher-risk patients (FFRCT ≤0.80) in whom further testing with invasive coronary angiography and possibly intervention may be needed. Further studies assessing the risk and optimal management strategy in patients undergoing first-line CTA with selective FFR_CT testing are needed.

Abstract

Recommended Article

Coronary CT Angiographic and Flow Reserve-Guided Management of Patients With Stable Ischemic Heart Disease

ABSTRACT